The Doxorubicin Hydrochloride Inject, cataloged under National Stock Number 6505-01-279-4075, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Erbamont Inc Adria Laboratories Div. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-279-4075 |
| Primary Part Number | NDC00013-1156-79 |
| Item Name | Doxorubicin Hydrochloride Inject |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Erbamont Inc Adria Laboratories Div |
| Status | ACTIVE |
| Primary Container Content Quantity | 25.000 MILLILITERS |
| Supplementary Features | NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, SINGLE DOSE |
| Protective Storage Feature | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Active Medicament Medicinal Strength | 2.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00013-1156-79 PRIMARY | Erbamont Inc Adria Laboratories Div (USA) |
| Reference | Meaning |
|---|---|
| BEDFORD LABS | 5/1 Secondary reference U.S. Government activity |
| NDC55390-0237-01 | 3/2 Design control — primary reference U.S. Government activity |
| ADRIAMYCIN PFS | 5/1 Secondary reference Erbamont Inc Adria Laboratories Div |
NSN 6505-01-279-4075 is a Doxorubicin Hydrochloride Inject, manufactured by Erbamont Inc Adria Laboratories Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-279-4075 has 1 manufacturer part number on file: NDC00013-1156-79 (Erbamont Inc Adria Laboratories Div).
Key specifications for NDC00013-1156-79: Primary Container Content Quantity: 25.000 MILLILITERS; Supplementary Features: NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL, SINGLE DOSE. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.